Join to View Full Profile
22 S Greene StBaltimore, MD 21201
Phone+1 410-328-8668
Fax+1 410-328-6896
Dr. Zandberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 2009 - 2012
George Washington UniversityResidency, Internal Medicine, 2005 - 2008
Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 2005
Certifications & Licensure
PA State Medical License 2018 - 2026
MD State Medical License 2012 - 2019
VA State Medical License 2005 - 2010
DC State Medical License 2005 - 2008
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cetuximab With or Without Tivantinib in Treating Patients With Head and Neck Cancer That Is Recurrent, Metastatic, or Cannot Be Removed by Surgery Start of enrollment: 2012 Aug 20
- Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Start of enrollment: 2014 Oct 23
- Reirradiation With Pembrolizumab in Locoregional Inoperable Recurrence or Second Primary Squamous Cell CA of the Head and Neck Start of enrollment: 2016 Mar 09
- Join now to see all
Publications & Presentations
PubMed
- Circulating tumor DNA in Non-Viral head and neck squamous cell Carcinoma: A systematic review and Meta-Analysis.Vanessa Helou, Nana-Hawwa Abdul-Rahman, Suet Kee Loo, Shou-Jiang Gao, Jose P Zevallos
Oral Oncology. 2025-10-17 - Clinical and social determinants of survivorship clinic attendance in head and neck cancer.Maryanna S Owoc, Katie M Carlson, Marci Lee Nilsen, Yvonne M Mowery, Kevin J Contrera
Journal of Cancer Survivorship. 2025-09-08 - 1 citationsRandomized Phase II Study of Concurrent Versus Sequential Pembrolizumab in Combination With Chemoradiation in Locally Advanced Head and Neck Cancer.Dan P Zandberg, Lazar Vujanovic, David A Clump, Brian P Isett, Hong Wang
Journal of Clinical Oncology. 2025-08-10
Journal Articles
- Intratumor Genetic Heterogeneity in Squamous Cell Carcinoma of the Oral CavityScott E Strome, John C Papadimitriou, Dan P Zandberg, Head & Neck
Press Mentions
New Findings from Immunotherapy Trial Pave the Way for Advanced Skin Cancer TreatmentsMay 31st, 2025- Combination Immunotherapy Before Surgery May Increase Survival in People with Head and Neck CancerMarch 13th, 2025
- OmniSeq and UPMC Collaborate to Launch Novel Phase II Prospective Head and Neck Cancer Clinical StudyJanuary 28th, 2021
- Join now to see all
Grant Support
- Small extracellular vesicles as biomarkers of prognosis and response to therapy in head and neck cancerUNIVERSITY OF PITTSBURGH AT PITTSBURGH2023–2027
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
